HIP
MGCD

Hatteras Investment Partners’s MGC Diagnostics Corporation MGCD Stock Holding History

Hatteras Investment Partners’s Portfolio MGCD Stock Details MGCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-21,700
Closed -$139K – 212
2014
Q4 		$139K Hold
21,700
– – 0.05% 168
2014
Q3 		$148K Buy
+21,700
New +$168K 0.05% 190

Other funds holding MGCD

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IM
ISF Management New York $47.4M AUM 6.56% 1-Year Est. Return
LBIM
Land & Buildings Investment Management Stamford, Connecticut $591M AUM 10.19% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Hatteras Investment Partners's MGCD Position: Q1 2015 in Review

Hatteras Investment Partners sold out of MGC Diagnostics Corporation (MGCD) in Q1 2015, closing a stake of 21,700 shares — an estimated $139K sold.

Hatteras Investment Partners first reported a position in MGCD in Q3 2014 and held it in 2 quarters. The position peaked at $148K in Q3 2014. 16 funds tracked by Wall St. Rank hold MGCD as of Q1 2015.

  • Hatteras Investment Partners reported no remaining MGC Diagnostics Corporation position as of Q1 2015 after selling out during the quarter.
  • Hatteras Investment Partners sold 21,700 MGC Diagnostics Corporation shares in Q1 2015, an estimated $139K.
  • Hatteras Investment Partners first reported a position in MGC Diagnostics Corporation in Q3 2014 and held it in 2 quarters.
  • Hatteras Investment Partners's MGC Diagnostics Corporation position peaked at $148K in Q3 2014.
  • 16 funds tracked by Wall St. Rank held MGC Diagnostics Corporation as of Q1 2015.

Based on Hatteras Investment Partners's 13F filing for Q1 2015, filed 15 May 2015.